Does big pharma’s R&D justify high drug prices?
What we can learn from the Covid vaccine success
Have Covid-19 vaccines changed intellectual property for good?
China vs. India: the fight for pharma supremacy
How Covid is building trust in Big Pharma
Is it time to rehabilitate psychedelics?
The real dangers of vaccine hesitancy
Can weight-loss drugs tackle the obesity crisis?
How COVID-19 is evolving the R&D landscape
Medical cannabis and the ongoing fight for access
What are new antibiotics really worth?
India: a global pharma powerhouse
Don't have an account?
Fill in your email to sign up
Raconteur is now a B Corp!
Find out how we did it, and what it means for our readers.